Skip to content

Scoping review and interpretation of myofascial pain/fibromyalgia syndrome: An attempt to assemble a medical puzzle

Plaut S · PLoS One · 2022

📚Systematic Scoping Review📄n=799 studies included🔬High Theoretical Impact

Evidence Level

MODERATE
75/ 100
Quality
4/5
Sample
5/5
Replication
3/5
🎯

OBJECTIVE

To systematically review studies on myofascial pain syndrome and propose an organic mechanism explaining how it can progress to fibromyalgia

👥

WHO

Patients with myofascial pain syndrome, trigger points, and fibromyalgia

⏱️

DURATION

Systematic search from September 2020 to September 2021

📍

POINTS

Myofascial trigger points and tender points distributed throughout the body

🔬 Study Design

799participants
randomization

Studies on MPS and trigger points

n=95

Analysis of clinical features

Studies on fascial properties

n=47

Biomechanical analysis

Studies on myofascial treatment

n=209

Analysis of therapeutic efficacy

Studies on fibromyalgia

n=93

Pathophysiologic analysis

⏱️ Duration: Review spanning multiple decades of research

📊 Results in numbers

45–54%

Prevalence of trigger points in the population

47 billion USD

Annual cost of myofascial pain in the US

33.5 mmHg

Intramuscular pressure in fibromyalgia

90% within 4 minutes

Fascial stress relaxation

Percentage highlights

45–54%
Prevalence of trigger points in the population
90% within 4 minutes
Fascial stress relaxation

📊 Outcome Comparison

Mean intramuscular pressure

Fibromyalgia
33.5
Healthy controls
12.2
💬 What does this mean for you?

This study proposes that myofascial pain and fibromyalgia may have a mechanical origin in the fascia (the tissue that surrounds muscles), where specialized cells called myofibroblasts create chronic tension. A sedentary lifestyle and repetitive movements can trigger this process, while appropriate movement and exercise can prevent and treat it.

📝

Article summary

Plain-language narrative summary

This scoping review systematically examines 799 studies on myofascial pain syndrome (MPS) and fibromyalgia, proposing a new theoretical model for understanding these conditions. The author suggests that both conditions represent manifestations of a common pathologic process centered on the fascia, termed 'fascial armoring.' Fascia is a connective tissue that permeates the entire body, surrounding muscles, bones, and organs. It has unique viscoelastic properties that allow reversible adaptation to mechanical stress through tensional relaxation. When subjected to prolonged stress or immobilization, fascia undergoes changes in hyaluronic acid concentration and myofibroblast activity.

Myofibroblasts are specialized cells that differentiate from normal fibroblasts in response to mechanical stress, developing alpha-actin fibers that generate sustained contraction in the tissue. Unlike reversible muscle contraction, myofibroblast contraction can persist for long periods through extracellular matrix remodeling. The 'fascial armoring' model proposes that trigger points represent areas where myofibroblasts have created 'tensional shielding' to protect tissues from excessive stress. However, this protective adaptation can become pathologic when generalized.

Fascial tension can propagate through tensegrity principles, in which structures are stabilized by continuous tension with discontinuous compression. This would explain how local dysfunction can cause distant symptoms and why fibromyalgia presents a specific pattern of painful points adjacent to bony prominences. Sedentary lifestyle emerges as a principal risk factor, since fascia evolutionarily adapted to continuous movement. Immobilization leads to changes in collagen, increased myofibroblast density, and formation of pathologic adhesions as early as the first week.

Paradoxically, movement and exercise prevent and reverse these changes through multiple mechanisms: fascial energy dissipation, mechanical disruption of fibers, local heating that breaks down hyaluronic acid, increased lymphatic flow, and natural pandiculation. Clinically, MPS manifests through trigger points with abnormal electrical activity and palpable taut bands. The 'satellite' phenomenon — in which trigger points induce new distant points — can be explained by fascial tensional propagation. When this process generalizes, it can progress to fibromyalgia, characterized by elevated intramuscular pressures (mean 33.5 mmHg vs.

12.2 mmHg in controls) that exceed the criteria for chronic compartment syndrome. Cardiovascular evidence in fibromyalgia includes reduced peripheral blood flow, capillary dilations, and arterial alterations, consistent with generalized fascial compression. Metabolic findings show elevation of interstitial lactate, glutamate, and pyruvate, suggesting low-grade ischemia. Genomic studies identify mitochondrial polymorphisms associated with increased risk.

Intriguing phenomena such as complete resolution of fibromyalgia after laparoscopic surgeries or parathyroidectomy may be explained by inadvertent fasciotomy releasing tension from the tensegrity network. The model predicts that different surgeries will have variable effects depending on how they affect fascial tensegrity — some relieving, others exacerbating symptoms. Therapeutically, needling emerges as a common modality, possibly functioning as 'global percutaneous fasciotomy' that disrupts pathologic connections in the tensegrity network. The proposed mechanism involves creating weak points where internal forces rupture fibers, releasing tension and inducing myofibroblast apoptosis.

The approach should respect tensegrity principles, releasing tension gradually from the periphery toward the center to avoid pathologic redistribution of forces. This model unifies several 'functional syndromes' under a common mechanism of tension-tensegrity generated by myofibroblasts, explaining the epidemiologic overlap between fibromyalgia, irritable bowel syndrome, chronic fatigue, and other conditions. Risk factors include not only sedentary lifestyle but also diet, medications, and environmental exposures that induce myofibroblasts. The model has limitations, not fully explaining central neurologic aspects or psychosocial factors, but it offers a unifying framework for understanding mechanical aspects often neglected in these prevalent conditions.

Strengths

  • 1Comprehensive review of 799 studies from multiple disciplines
  • 2Proposal of an evidence-based unifying theoretical model
  • 3Integration of biomechanical, cellular, and clinical aspects
  • 4Explanation for previously unexplained clinical phenomena
⚠️

Limitations

  • 1Primarily theoretical in nature without direct experimental validation
  • 2Limited focus on central sensitization mechanisms
  • 3Need for clinical studies to test the proposed hypotheses
  • 4Some psychosocial aspects not fully integrated
Dr. Marcus Yu Bin Pai

Expert Commentary

Dr. Marcus Yu Bin Pai

MD, PhD · Pain Medicine · Physical Medicine and Rehabilitation · Medical Acupuncture

Clinical Relevance

The proposal of a unifying model for myofascial pain syndrome and fibromyalgia, based on tensegrity dysfunction of the fascia mediated by myofibroblasts, has direct practical implications for those running a musculoskeletal pain clinic. The prevalence of trigger points in 45 to 54% of the population reinforces that we are facing a public health problem — the 47 billion dollars in annual costs in the US captures the scale of that impact. For the physiatrist, the model guides concrete decisions: sedentary lifestyle is no longer just a behavioral risk factor and becomes a measurable biomechanical trigger of fascial densification and myofibroblast recruitment. This justifies prescribing exercise as a disease-modifying intervention, not merely an analgesic one. Patients with established fibromyalgia, concomitant irritable bowel syndrome, or chronic fatigue fit within the model's spectrum, allowing more integrated clinical reasoning in multidisciplinary therapeutic planning.

Notable Findings

Two findings deserve special attention. The first is the intramuscular pressure of 33.5 mmHg recorded in patients with fibromyalgia — a value that exceeds the diagnostic threshold for chronic exertional compartment syndrome, which reframes the pathophysiology of this condition in mechanically tangible terms. The second is fascial stress relaxation of 90% in only four minutes, a finding that directly informs the minimum hold time in manual release techniques and needling. The hypothesis that needling functions as a global percutaneous fasciotomy — inducing myofibroblast apoptosis and disrupting pathologic connections in the tensegrity network — provides a coherent mechanistic substrate for what we observe clinically. The tensegrity explanation for the satellite trigger-point phenomenon, where local dysfunction propagates tension and generates new distant foci, also elegantly organizes referred pain patterns that often confound clinicians less familiar with myofascial medicine.

From My Experience

In my pain and rehabilitation clinic, the tensegrity model described in this review aligns well with what I have observed over decades treating myofascial pain. I usually see initial response to dry needling within three to five sessions when the presentation is localized — cervical or lumbar trigger points without generalization. In patients who already display the diffuse pattern suggestive of fibromyalgia, the response is slower and generally requires combination with a supervised progressive aerobic exercise program, since without continuous movement pathologic refasciculation returns. I have observed that very sedentary patients, especially those in prolonged remote work with static posture, form the profile that most often arrives in the office with already established satellite points. The periphery-to-center progression in needling, which the article theoretically grounds, is a practice we already adopted empirically in the service — and seeing this sequence supported by tensegrity principles reinforces the rationale of the approach. For maintenance, eight to twelve sessions in semiannual cycles have been sufficient in most responders.

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture.

Full original article

Read the full scientific study

PLoS One · 2022

DOI: 10.1371/journal.pone.0263087

Access original article

Scientific Review

Marcus Yu Bin Pai, MD, PhD

Marcus Yu Bin Pai, MD, PhD

CRM-SP: 158074 | RQE: 65523 · 65524 · 655241

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.

Learn more about the author →
⚕️

Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.

Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.